Boehringer Ingelheim


Boehringer Ingelheim Pharmaceuticals, Inc., the U.S. subsidiary of Boehringer Ingelheim, headquartered in Germany, operates globally with 44,000 employees. The company is committed to researching, developing, manufacturing, and marketing novel products of high therapeutic value for human and veterinary medicine. Visit and follow us on Twitter at @boehringerus.

Exhibitor Level: 
Silver Level
Booth Number: